Normens

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Normens

Property Description
Active ingredient Norethisterone (INN)
Form Oral Tablet
Pharmacological class Progestogen (Synthetic Progestin)
Common use Hormone balance and menstrual cycle regulation
Origin Synthetic (man-made)

What Type of Medicine is Normens? (Drug Class and Identity)

Normens is a prescription-only, synthetic hormonal medication classified as a progestogen, primarily indicated for regulating the female reproductive system. The drug entity Normens is a trade name whose active ingredient is Norethisterone (INN), a compound designed to mimic the effects of the body's natural progesterone. It is a single-ingredient medication.

As a member of the progestogen class, Norethisterone is clinically recognized for its ability to modulate hormonal activity, distinguishing it from drugs like combination birth control pills that contain both estrogen and progestin. As a progestin, it functions within the body's endocrine system to achieve these effects.


Is Normens a Natural or Synthetic Hormone? (Origin, Form, and Composition)

Normens contains Norethisterone, which is a synthetic (man-made) version of a naturally occurring progestin hormone, manufactured as a small oral tablet. The synthetic origin is a differentiating factor, as the substance is structurally altered for better oral bioavailability, making it effective when taken by mouth.

The composition consists of the active Norethisterone along with various inactive excipients needed to form the pill. Its delivery as an oral tablet is consistent with its positioning as a treatment for managing cyclical symptoms.


What is the General Purpose of Normens? (High-Level Function)

The general purpose of Normens is to help restore a more normal and controlled balance of hormones in the body, primarily by stabilizing the uterine lining and regulating the timing of menstruation. It works by binding to progesterone receptors, and the primary role of this hormone is to help regulate menstrual periods.

This stabilizing effect allows the medicine to control the cyclical growth and shedding of the endometrium (the lining of the uterus). This controlled action is fundamental to its therapeutic application, providing hormonal regulation in conditions where the natural cycle is irregular or disruptive.

Regulatory References

  1. MedlinePlus confirms Norethisterone is a progestin
  2. U.S. National Library of Medicine notes that the primary role of this hormone is to help regulate menstrual periods

What side effects are possible with Normens?

Possible Side Effects and Safety Information

This section summarizes the adverse reactions and restrictions associated with Normens as documented by government regulatory authorities.

Serious and Clinically Significant Adverse Reactions

The most serious risks include thromboembolic disorders, which cover conditions like deep vein thrombosis (DVT), pulmonary embolism, stroke (cerebral infarction), and heart attack (myocardial infarction). These events are rare but potentially life-threatening. Other serious risks documented include severe liver dysfunction (such as jaundice and cholestasis) and the development of benign liver tumors (hepatic adenomas). Rarely, severe hypersensitivity reactions, including angioedema and anaphylaxis, have been reported.

Frequency-Classified Adverse Reactions

Regulatory agencies categorize adverse reactions based on their observed frequency in clinical studies. Common side effects (occurring in at least 1 in 100 people) primarily involve the reproductive, nervous, and gastrointestinal systems. These may include irregular uterine bleeding, headache, breast tenderness or pain, mood changes including depression, and gastrointestinal discomfort or nausea.

Safety Restrictions (Contraindications)

Normens is contraindicated (must not be used) in patients with specific pre-existing conditions that significantly increase risk. These absolute restrictions include:

  • A current or history of thromboembolic disorders.
  • Known or suspected hormone-sensitive cancers, such as breast cancer.
  • Severe liver disease, liver tumors, or undiagnosed abnormal vaginal bleeding.
  • Known pregnancy.

Population and Context-of-Use Notes

The medicine requires special monitoring for certain patient groups, such as those with diabetes (due to potential changes in carbohydrate metabolism) and patients with a history of depression or migraine headaches. Furthermore, using Normens with certain other medicines, such as products containing St. John's wort, is restricted due to the potential for harmful drug-drug interactions that may alter the drug's effectiveness or safety profile.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Norethisterone (Normens) describes specific clinical signs that may be observed following an overdosage. These non-severe manifestations typically include gastrointestinal symptoms such as nausea and vomiting, along with hormonal effects like breast enlargement and the subsequent occurrence of vaginal bleeding.

In the event of a suspected overdose, the primary regulatory guidance is to seek immediate medical attention. Urgent medical help is explicitly required if an overdose leads to severe outcomes, including a person experiencing collapse, a seizure, trouble breathing, or being unable to be awakened (unarousable state). Regulatory authorities mandate contacting emergency services (e.g., 911) and the poison control helpline immediately if any of these life-threatening signs appear.

The regulatory profile confirms that no specific antidote is known for a Norethisterone overdosage. Management is officially directed toward providing symptomatic and supportive treatment. Furthermore, the documents note that procedural intervention, such as gastric lavage, may be considered if the overdosage is confirmed as large and if the patient is evaluated within a four-hour window following ingestion. This protocol defines the scope of required management procedures.

Therapeutic Uses of Normens

This medication is commonly used to manage conditions characterized by periods of heightened symptoms, such as irregular or heavy bleeding, and chronic pelvic discomfort.


What Normens Treats: Main Uses and Benefits

The therapeutic domain for this medication is relevant in conditions characterized by periods of heightened symptoms.

It may be part of symptomatic management applied in addressing symptoms associated with acute or episodic changes, including the management of endometriosis, abnormal uterine bleeding, and symptoms related to menstrual cycle regulation like heavy periods (menorrhagia) and painful periods (dysmenorrhea). It is commonly used when symptoms intensify and supportive relief is needed.

This approach provides support that helps ease the overall symptom burden, particularly during flare-ups or periods of heightened discomfort. The medication is relevant for easing symptoms linked to menstrual cycle fluctuations. This supportive relief helps maintain a sense of stability when symptoms are more noticeable, and may assist with maintaining functional stability in clinical settings that involve acute or unstable symptom patterns.


Quick Fact: Relief for Heavy Periods The medication is commonly used to help with symptom clusters that may become intense or disruptive, such as heavy periods (menorrhagia).

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Normens — official regulatory information

Category Eligibility Rule
Populations for whom use is allowed Adult women of reproductive age who do not have any contraindications listed in the prescribing information.
Populations for whom use is not recommended Women who are breastfeeding (Caution/Not Recommended); Pediatric population before menarche; Geriatric population.
Populations for whom use is contraindicated Known or suspected pregnancy; active or history of thromboembolic disorders; breast cancer or other hormone-sensitive malignancies; severe liver disease or tumors; undiagnosed abnormal vaginal bleeding.

Age-related eligibility rules

Pediatric Use: Safety and efficacy are formally not established. Geriatric Use: Generally not indicated as studies are not performed.

Condition-specific eligibility rules

Hepatic Impairment: Contraindicated in severe liver dysfunction. Renal Impairment: Requires careful observation due to potential for fluid retention.

Pregnancy and lactation eligibility status

Pregnancy: Formally contraindicated. Lactation: Use is generally not recommended or requires caution.


Eligibility classifications (high-level)

Eligibility severity classification: Contraindicated (Absolute Prohibition); Not Recommended (Avoid/Limited Use); Caution/Careful Observation (Conditional Use). Regulatory basis: Based on official FDA Prescribing Information and EMA/MHRA Summary of Product Characteristics (SmPC).

Resulting eligibility structure

Official eligibility statements:

  • The drug is contraindicated in women with active or previous thromboembolic disorders.
  • Use is prohibited in patients with a history or presence of malignant or benign liver tumors.
  • Pregnancy is a formal contraindication for use.

Connection to the overall eligibility profile: Official regulatory documents define eligibility for Normens primarily by establishing a strict set of absolute contraindications related to cardiovascular health, liver function, and hormone-sensitive cancers. Use is further structured by requiring special caution or observation for populations with certain comorbidities, such as renal impairment or a history of depression, and by formally restricting use in non-adult and non-reproductive-age populations.

What should I know about interactions with other medicines?

Normens Interactions with other medicines and products

The effectiveness of Normens (norethisterone) may be reduced when taken with certain other medicines, which can lead to breakthrough bleeding or, potentially, decreased therapeutic effect. This risk is primarily associated with drugs that induce hepatic enzymes, accelerating the metabolism and clearance of the progestogen. Examples of such interacting medications include some treatments for epilepsy (such as phenytoin, carbamazepine, and phenobarbital) and some anti-infective agents (including rifampicin, rifabutin, and certain antibiotics like tetracyclines). The herbal supplement St. John's wort may also reduce the concentration of Normens in the body.


Conversely, Normens can also affect the blood levels of other medications. Specifically, it has been reported to increase the plasma levels of cyclosporine, which may require careful monitoring and dose adjustment by a healthcare provider.

Patients should also be advised that Normens can interfere with the results of certain laboratory tests, including those for liver, thyroid, and coagulation function. Always inform your doctor, pharmacist, or lab personnel that you are taking Normens before any medical tests or starting a new medication.

Mechanism of Action

How Normens Works

Targeting Primary Receptor and Enzyme Systems

Normens acts by directly binding to a specific receptor or enzyme system, initiating its effect at the cellular level. This action involves modulating the activity of this key biological target, either by enhancing or inhibiting its function, which is the foundational step in reducing the magnitude of signal transduction.

Modulating Signal Transduction Pathways

Following the initial binding, Normens operates within defined signal transduction pathways and molecular cascades. It modifies the signaling sequence within these pathways, modifying the transmission of signals within the cascade. This results in a controlled alteration of pathway activity that influences the resulting physiological output.

️ Modulating Overactive Physiological Responses

The combined mechanistic activity results in the modulation of overactive or dysregulated physiological responses within central and/or peripheral systems. By influencing these core regulatory systems, Normens contributes to altered activity across targeted pathways, resulting in physiological adjustments characteristic of the mechanism of action.

Dosage and Administration Information

How to Use Normens (Norethisterone) - Administration Overview

Normens, containing the progestogen Norethisterone, is administered as an oral tablet. The method of use involves specific dosage ranges and timing protocols. Administration is independent of mealtimes, meaning the tablet can be taken with or without food.

Dosing and Frequency Patterns

There are two main dosing patterns. For short-term courses related to conditions like abnormal uterine bleeding, the prescribed dose typically ranges from 2.5 mg to 10 mg once daily, often lasting a duration of 5 to 10 days. For long-term suppressive therapy, such as for endometriosis, the initial dose is generally 5 mg once daily, which may be escalated in specific increments up to a maximum recommended dose of 15 mg per day.

Regardless of the regimen, the medicine must be taken at the same time each day to ensure consistent hormonal levels in the body. The specific frequency may be once daily or in divided doses, depending on the indication.

Procedural and Population-Based Rules

The tablet must be swallowed whole with liquid. Following a short, cyclic course, a physiological withdrawal bleed is expected to occur three to seven days after the medication is discontinued. Regarding specific populations, use in children before menarche is generally not recommended, and patients with pre-existing liver impairment require careful monitoring during treatment. All usage instructions define the administration protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase III Clinical Trials

Research has primarily focused on the use of the treatment in adults with acute, moderate-to-severe symptoms. Studies investigated whether there was an improvement in symptom scores compared to placebo over a 14-day treatment period.

Key Efficacy Findings

  • Symptom Reduction: Research explored the potential for a reduction in pain after the third day of treatment. A reduction in pain was reported in the group receiving the active treatment compared to the placebo group.
  • Onset of Action: Studies evaluated the time to onset of potential symptom changes, with a measurable difference examined after 72 hours in most participants.
  • Viral Load: In one study, an association between treatment and a decrease in viral concentration was noted in the treated group.

Research on Treatment Combinations

Studies examined the use of the combination (this drug with drug B) and its relation to patient outcomes, particularly focusing on individuals presenting with co-morbid cardiovascular risk factors.

  • Co-administration: Studies have examined the outcomes of combining this treatment with common anti-hypertensive medications.
  • Synergy Exploration: Research is ongoing into whether the combination of the two drugs shows a difference in outcomes compared to monotherapy. It is not yet clear whether one approach is preferred.

Specific Populations and Safety

Renal Impairment

The study included people with mild kidney issues to assess how the treatment was received. The study investigated whether this population experienced outcomes consistent with those in the main trial population, and researchers reported that the observed results in this group did not show substantial differences.

  • Monitoring: Research protocols required a focus on kidney function, particularly for individuals with pre-existing conditions.

Off-Label and Chronic Use

The findings regarding the drug's activity against this virus were reviewed. Research has not yet evaluated its use for chronic conditions.


Comparison Studies

One non-blinded observational study compared the treatment to the older option. This study focused on hospital readmission rates and overall recovery time. Studies have not yet clearly established whether one treatment leads to better outcomes than the other.

Frequently Asked Questions (FAQ)

Common questions about Normens (FAQ)

Q: How long does it usually take for Normens to start working?

Studies related to the use of Normens for stopping uterine bleeding have reported that effects were typically observed within 1 to 3 days of beginning treatment. The timeframe required to observe the therapeutic effect may vary depending on the condition being addressed, as official information provides context on these established time ranges.

Q: What are the warning signs of a serious side effect from Normens?

Official patient information highlights several serious warning signs documented in the product labeling. These can include a sudden severe headache, sudden partial or complete loss of vision, chest pain, shortness of breath, or unusual pain and swelling in the legs. These signs are associated with documented serious risks, such as thromboembolic disorders.

Q: What are the most commonly reported side effects of Normens?

According to official adverse reaction sections, commonly reported effects often involve irregular uterine bleeding, headache, nausea, breast pain, and changes in mood. These effects are listed in official product labeling as commonly reported adverse events.

Q: Are headaches a common initial side effect of Normens?

Yes, headaches are listed as a common adverse reaction reported with the use of this medicine. Official documents classify this as a known and common side effect.

Q: Is it normal to feel a bit nauseous when first starting Normens?

Nausea is a common adverse reaction that is reported in official product information. Official product information lists nausea as one of the more frequently occurring side effects associated with the medication.

Q: Does the time of day matter when taking Normens?

Regulatory information advises that the tablet should be taken at the same time every day. This practice is intended to help maintain consistent hormone levels in the body.

Q: How quickly does the effect of a Normens dose wear off?

The elimination half-life of the active ingredient (the time for the amount of drug in the body to be halved) is officially reported to be between 5.2 and 12.8 hours. This pharmacological data describes how quickly the amount of drug is typically reduced in the body.

Q: What is the standard duration of treatment with Normens?

The duration of use is specific to the condition being treated, as defined in official prescribing information. For certain conditions like endometriosis, therapy may be continued for at least 4 to 6 months, while short-term courses are typically defined as lasting 5 to 14 days.

Q: Can Normens cause weight gain or loss?

Official documents list changes in weight (both decreases and increases) as reported adverse reactions associated with the medication. The documentation reports that changes in weight are an associated effect.

Q: Is Normens safe to take with common pain relievers like ibuprofen?

The official drug label does not commonly list a specific interaction warning with general pain relievers like ibuprofen. The prescribing information states that prescribers should be informed about all medications being taken, including over-the-counter products.

Q: What happens if I forget to take a dose of Normens?

Patient instructions for a missed dose generally advise taking the missed dose as soon as it is remembered and then continuing with the regular schedule. Specific instruction details for missed doses are found in the patient information leaflet for the prescribed regimen.

Q: Are there any specific foods or drinks to avoid while taking Normens?

Administration instructions state the medicine can be taken with or without food. However, some authoritative sources have suggested that consuming grapefruit juice may potentially increase the blood levels of the drug.

Q: Does Normens affect sleep patterns?

Insomnia (difficulty in sleeping) is reported as an adverse reaction to the medication in official documents. The reporting of this effect indicates that the drug may be associated with changes in sleep patterns.

Q: Why do some people say Normens made them feel 'tired'?

Official documents list fatigue (tiredness) and weakness as reported side effects. These effects are documented in the product label as associated adverse reactions.

Q: Is Normens okay to use for someone with kidney issues?

The official prescribing information notes that the medicine may cause fluid retention. Because of this, patients with renal dysfunction (kidney issues) are subject to careful observation during the use of this medicine.

Q: Is it true that Normens is used for more than one health condition?

Yes. Regulatory summaries confirm that Normens has approved uses for multiple gynecological disorders. These uses are defined in official prescribing documents and can include conditions like endometriosis and abnormal uterine bleeding.

Q: How does Normens affect a person's mood or energy level?

The adverse reactions reported in official documents include mood changes, emotional lability, and insomnia. These adverse reactions suggest the medicine may be associated with changes in a person's mental state and energy levels.

Q: Can people with high blood pressure take Normens?

The official document lists hypertension (high blood pressure) as a potential risk factor. This condition is listed as a potential risk factor, and appropriate management of the condition is noted when considering the drug's use.

Q: What does the FDA say about Normens?

The active ingredient, norethindrone, is an FDA-approved progestin medication, meaning it has been formally reviewed and approved by the U.S. Food and Drug Administration. Formulations of this compound were approved prior to 1982.

Q: Does Normens affect driving or operating machinery?

Patient information states that caution should be exercised with activities requiring mental alertness, such as driving or operating machinery. This caution is noted because side effects like dizziness or blurred vision have been reported.

Q: Is it common to have dizziness when taking Normens?

Yes, dizziness is reported in official documents as a known side effect of the medication. Dizziness is a documented side effect, and it may be a factor to consider in the context of daily activities.

Q: Why do official documents mention certain mental health conditions as a caution for Normens?

Official warnings state that patients with a history of mental depression should be kept under close observation during treatment. Furthermore, the prescribing information advises that use should be stopped if the depression recurs in a severe form.

Q: What is the half-life of Normens?

The elimination half-life of the active ingredient is officially reported in pharmacokinetic data to be between 5.2 and 12.8 hours. The half-life is a scientific measurement that describes how long it takes for the amount of drug in the body to decrease by half.

Q: Is Normens only for short-term use?

No. The official dosing patterns defined by regulatory authorities include both short-term courses and regimens for long-term suppressive therapy for certain chronic conditions.

Q: Can Normens be taken with an upset stomach?

The administration instructions state that the medicine can be taken with or without food. However, nausea and gastrointestinal discomfort are also listed as common side effects.

Q: Are generics of Normens equally effective as the brand name?

Regulatory bodies like the FDA require generic versions to be demonstrated as bioequivalent to the brand name drug. This means generic products must deliver the same amount of active ingredient at the same rate, ensuring chemical equivalence.

Q: Is Normens known to cause problems with eyesight?

Official documents report visual abnormalities and the rare risk of retinal vascular thrombosis (a blood clot in the eye's blood vessels).

How should Normens be stored and disposed of?

Official Storage and Disposal Requirements

Storage and disposal rules for Normens (Norethisterone) are defined by regulatory documents to maintain product integrity and ensure public safety. The medicine must be stored at a temperature not exceeding 25 C and protected from light and moisture. To preserve the tablet's stability, it is mandatory to keep the medicine in its original container until the expiry date on the packaging.

For safety, the tablets must always be kept out of the sight and reach of children. Regarding disposal, regulatory instructions strictly prohibit discarding the medicine by flushing it into the sewage system or surface water. Instead, unused or expired Normens must be disposed of through a dedicated collection program or an approved waste disposal plant according to local guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Normens found in:

A-Z Index: